Intentional nontherapy in long QT syndrome

Area of Science:

• Cardiology
• Genetics
• Clinical Medicine

Background:

• International guidelines recommend universal beta-blocker therapy for long QT syndrome (LQTS).
• Therapy is classified as Class I for symptomatic patients or those with QTc ≥470 ms, and Class II for asymptomatic patients with QTc <470 ms.

Purpose of the Study:

• To evaluate the outcomes of a carefully selected cohort of LQTS patients managed with an observation-only strategy.
• To assess the efficacy of intentional non-treatment in low-risk LQTS individuals.

Main Methods:

• A retrospective registry of LQTS patients was utilized.
• Clinical phenotype and genotype data were collected from electronic health records.

Main Results:

• Of 661 LQTS patients, 55 asymptomatic individuals (8.3%) were managed with observation only.
• No LQTS-triggered cardiac events occurred during a mean follow-up of 7.5 years.
• The observation group was older at diagnosis and had lower QTc values compared to the treated cohort.

Conclusions:

• An observation-only strategy may be suitable for highly selected, asymptomatic LQTS patients with older age at diagnosis and QTc <470 ms.
• This approach yielded excellent outcomes and improved quality of life compared to beta-blocker treatment.
• Prophylactic implantable cardioverter-defibrillators are not recommended for this low-risk LQTS profile.